| Previous Close | 0.180 |
| Open | 0.190 |
| Volume | 4,410,900 |
| Avg. Volume (3M) | 564,404 |
| Market Cap | 58,058,680 |
| Price / Earnings (TTM) | 19.00 |
| Price / Sales | 0.940 |
| Price / Book | 0.610 |
| 52 Weeks Range |
| Profit Margin | 3.77% |
| Operating Margin (TTM) | 2.69% |
| Diluted EPS (TTM) | 0.010 |
| Quarterly Revenue Growth (YOY) | 0.50% |
| Quarterly Earnings Growth (YOY) | 3.00% |
| Total Debt/Equity (MRQ) | 10.98% |
| Current Ratio (MRQ) | 3.30 |
| Operating Cash Flow (TTM) | 1.64 M |
| Levered Free Cash Flow (TTM) | -8.02 M |
| Return on Assets (TTM) | 0.46% |
| Return on Equity (TTM) | 2.29% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (MY) | Mixed | Bearish |
| Medical Instruments & Supplies (Global) | Bearish | Bearish | |
| Stock | ADVENTA | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | 0.00 |
|
Adventa Bhd is engaged in the business of medical services and related supplies manufacturing. The company's segments include Healthcare Business, Warehousing provider, and Corporate. It generates maximum revenue from the Healthcare Business segment. The healthcare business segment comprises the supply of healthcare and related products and services to hospitals, healthcare centers, and pharmacies. Previously, it also included the renal dialysis business which is both for home and center-based treatments, serving both the domestic and export markets. Geographically, it derives a majority of its revenue from Malaysia. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 53.95% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 07 Jul 2025 | Announcement | DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period |
| 07 Jul 2025 | Announcement | Changes in Director's Interest (Section 219 of CA 2016) - MR TOH SENG THONG |
| 23 Jun 2025 | Announcement | General Meetings: Outcome of Meeting |
| 30 May 2025 | TheEdge | Tropicana group CEO Mark Victor redesignated as non-executive director |
| 20 May 2025 | Announcement | Quarterly rpt on consolidated results for the financial period ended 31/03/2025 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 14 Jan 2020 | 30 Dec 2019 | 22 Jan 2020 | 0.07 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2020 | 0.070 | 1 | 5.34 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |